✨ Free AI Report
Algernon Health Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Algernon Health Inc.
Company Research

Algernon Health Inc.: Business Overview, Financials & Competitive Analysis

Algernon Health Inc. operates as a clinical stage pharmaceutical development company focused on developing therapeutic drugs for non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program...

Analyst-debate audio for Algernon Health Inc.

AskCyborg analysts argue the bull and bear cases for Algernon Health Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
3/ 10Challenged

Cyborg Score thesis

Pre-revenue clinical-stage biotech with dual pipeline (drug development and neuroimaging infrastructure) facing significant...

Read the full analyst-debate transcript →
Industry Biotechnology
5 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 5, 2026
AI-Verified Research
30+ Page Report

Get the Latest Algernon Health Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Algernon Health Inc. Overview

Pro stress-test →

Algernon Health Inc. operates as a clinical stage pharmaceutical development company focused on developing therapeutic drugs for non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke programs. The company was incorporated in 2015 and is headquartered in Vancouver, Canada.

Strategic Profile

Pro stress-test →

The company's pipeline includes repirinast for chronic kidney disease treatment and N,N-Dimethyltryptamine for treating strokes and traumatic brain injuries. Algernon is expanding into neuroimaging infrastructure, opening brain-dedicated PET scanning clinics under the NovaScan Neuroimaging Clinics brand in the U.S., with the first location announced at HCA Florida University Medical Office Building in March 2026.

Competitive Landscape

Pro stress-test →

Algernon operates in two distinct competitive spaces: (1) clinical-stage biotech drug development against larger pharmaceutical companies and specialized biotech focused on kidney disease, liver disease, and neurological indications; (2) specialized neuroimaging infrastructure competing with regional radiology providers and established neuroimaging networks. Limited direct competitors in rare disease indications, but capital constraints limit competitive reach.

Industry Context

Algernon Health Inc. operates in Biotechnology.

Key facts

Founded: 2015 · Headquarters: Vancouver, Canada · Employees: Not disclosed · Revenue: Estimated $0 (pre-revenue clinical-stage company) · Market cap: $1.71M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Algernon Health Inc..

  • Capital intensity high relative to market cap signals steep dilution trajectory.
  • Company signed CDN $4M equipment and financing agreement in October 2025 for four FDA-cleared PET scanners with option for six more. Neuroimaging clinic strategy represents asset-heavy pivoting away from pure drug development.
+1 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • April 2026Corporate name changed to Grey Matters Health Inc. and 10:1 share consolidation completed
  • March 2026First brain-dedicated PET scanning clinic announced at HCA Florida University Medical Office Building
  • +1 moreTrack every material event for Algernon Health Inc. as it happens. Explore monitoring →
Get alerted when Algernon Health Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Chinook TherapeuticsClinical-stage biotech focused on chronic kidney disease→Axsome TherapeuticsClinical-stage biotech for central nervous system and pain disorders→BiogenMultinational biotechnology company developing therapies for neurological and neurodegenerative diseases→Reata PharmaceuticalsClinical-stage biotech focused on kidney disease, liver disease, and metabolic disorders→Neurochem Inc.Clinical-stage biotech developing therapeutics for neurological and metabolic diseases→

Compare Algernon Health Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Algernon Health Inc. operates in Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biotechnology by Cyborg Score

Browse Biotechnology research →
NEW · MCP server

Ask your AI assistant about Algernon Health Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Algernon Health Inc. and its top competitor on Cyborg Score”
“What did Algernon Health Inc. do this quarter?”
“Is Algernon Health Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Algernon Health Inc. do?+
Algernon Health Inc. operates as a clinical stage pharmaceutical development company focused on developing therapeutic drugs for non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program...
What is Algernon Health Inc.'s Cyborg Score?+
Algernon Health Inc. has a Cyborg Score of 3/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Algernon Health Inc.'s main competitors?+
Named competitors include Chinook Therapeutics, Axsome Therapeutics, Biogen, Reata Pharmaceuticals. The full competitive landscape is in the AskCyborg report.
How can I get the full Algernon Health Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Algernon Health Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Algernon Health Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biotechnology research

Companies in the same sector and named competitors, ranked by Cyborg Score.

8Abivax SA8Bavarian Nordic A/S8Beam Therapeutics Inc.8CG Oncology, Inc.8Cogent Biosciences, Inc.8COMPASS Pathways plc8CSL Limited8Eckert & Ziegler SE8Krystal Biotech, Inc.8Legend Biotech7Biogen Inc.Top companies in Biotechnology by Cyborg Score